Nephros Inc. (NEPH)
1.50
-0.01 (-0.66%)
At close: Jan 14, 2025, 3:57 PM
1.50
0.00%
After-hours Jan 14, 2025, 03:58 PM EST
undefined% (undefined)
| Bid | 1.4 |
| Market Cap | 15.82M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.09 |
| PE Ratio (ttm) | -16.67 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.38 |
| Volume | 16,998 |
| Avg. Volume (20D) | 8,939 |
| Open | 1.54 |
| Previous Close | 1.51 |
| Day's Range | 1.50 - 1.60 |
| 52-Week Range | 1.36 - 3.83 |
| Beta | undefined |
About NEPH
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Sep 21, 2004
Employees 31
Stock Exchange NASDAQ
Ticker Symbol NEPH
Website https://www.nephros.com
Next Earnings Release
Nephros Inc. is scheduled to release its earnings on Mar 6, 2025,
during market hours.
Analysts project revenue of $3.57M, reflecting a 8.18% YoY growth and earnings per share of -0.01, making a -83.33% decrease YoY.
Analysts project revenue of $3.57M, reflecting a 8.18% YoY growth and earnings per share of -0.01, making a -83.33% decrease YoY.
